| March 2 |
ZymoGenetics Collaboration with Bristol-Myers Squibb Clears Review Under Hart-Scott-Rodino Antitrust Improvements Act |
| March 2 |
Obama Expected to Nominate Sebelius Health Secretary |
| March 2 |
Lilly Announces Leadership Changes |
| March 2 |
United States Files Suit Against Missouri-Based Pharmaceutical to Block Manufacturing and Shipping of Unapproved Drugs |
| March 3 |
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo |
| March 3 |
Bayer: Corporate Strategy Proves Effective in a Difficult Environment |
| March 3 |
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions |
| March 3 |
Epsilon Study Shows 'Healthy' Response to Email from Pharma Companies |
| March 3 |
FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility |
| March 3 |
Bristol-Myers Squibb Announces Organizational Changes; Names Four to Company's Executive Committee |
| March 4 |
Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer |
| March 4 |
Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations |
| March 4 |
Combined Use of Antiplatelet, Gastric Acid Medications Following Heart Attack or Angina Associated With Increased Risk of Death, Hospitalization |
| March 4 |
US Food and Drug Administration Stresses Science-Based Compliance and Open Lines of Communication for 2009 |
| March 4 |
Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case |
| March 4 |
Astellas Terminates Agreement on Antipsychotic Agent ASP2314/ACR-16 |
| March 5 |
Bradmer Implements Cash Conservation Plan |
| March 5 |
Sens. Dorgan, Snowe, Mccain, Stabenow Introduce Bipartisan Prescription Drug Imporation Bill |
| March 5 |
Sen. Grassley: It should be legal to buy prescription drugs from other countries |
| March 5 |
NICE Refuses Funding for Advanced Breast Cancer Treatment, Tyverb (lapatinib) |
| March 5 |
CVS Caremark May be Violating Privacy of Hundreds of Thousands of Floridians, According to CtW |
| March 6 |
Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve |
| March 6 |
Astellas to Nominate Two Directors and Submit Proposal to Remove Remaining Four Directors of CV Therapeutics |
| March 6 |
OPKO Health Announces Update on Phase III Clinical Trial of Bevasiranib |
| March 6 |
FDA Sends Gilead Letter Over Statements Made By Gilead Representative |
| March 6 |
Genentech Urges Shareholders to Take No Action With Respect to Revised Offer From Roche |
| March 6 |
Roche Increases Offer Price for Genentech Shares to US$ 93 Per Share and Extends Offer |
| March 9 |
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium |
| March 9 |
Merck and Schering-Plough to Merge |
| March 9 |
Consumer Watchdog: Health Insurers & Drug Companies Contributed $5.5 Million to Top 10 Senate and House Recipients Since 2005 |
| March 9 |
IDM Pharma's Mepact (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma |
| March 9 |
Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference |
| March 10 |
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene |
| March 10 |
CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety |
| March 10 |
Nurse Practitioners Don't Realize How Much Their Prescribing is Being Influenced By Drug Marketing |
| March 10 |
FDA Sends Genzyme Letter Over Conditions at Massachusetts Plant |
| March 10 |
R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges |
| March 11 |
Targacept Provides Update on TC-6499 and Pain Program in GlaxoSmithKline Alliance |
| March 12 |
Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation |
| March 12 |
Pharmaceutical & Medical Packaging News Magazine Launches Online Supplier Video Resource For Packaging Industry |
| March 12 |
Bipartisan Group of Members Introduces “Promoting Innovation and Access to Life-Saving Medicines Act” |
| March 12 |
Gilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per Share |
| March 12 |
EPIX Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results |
| March 12 |
Table Reservations Open to Healthcare Advertising Agencies for the 20th Annual Med Ad News Manny Awards |
| March 12 |
CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer |
| March 13 |
Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. |
| March 13 |
Approval of Clevudine for the Treatment of Chronic Hepatitis B in the Philippines |
| March 13 |
Synta Restructures Organization to Focus on New Priorities |
| March 13 |
Patrick Administration Passes Tough New Rules Governing Pharmaceutical and Medical Device Industries |
| March 13 |
New FDA Heads Must Resist Fear |
| March 16 |
Astellas to Terminate Offer for CV Therapeutics |
| March 16 |
WEEKLY ADDRESS: President Barack Obama Announces Key FDA Appointments and Tougher Food Safety Measures |
| March 16 |
Med Ad News Launches Online Forum Connecting Pharmaceutical Professionals With Industry Experts |
| March 16 |
Roche Acquires Innovatis AG to Complement Its Product Portfolio in the Rapidly Growing Area of Cellular Analytics |
| March 16 |
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer |
| March 17 |
Consumer Reports Poll: 66% of Americans Blindsided by Cost of Drugs; Many Not Taking Needed Medications |
| March 17 |
Med Ad News Magazine Announces Nominees for the 20th Annual Manny Awards as Well as Advertising Person of the Year |
| March 17 |
Cytos Biotechnology Announces Alignment of Resources Following Setback in the Development of its Hypertension Vaccine CYT006-AngQb |
| March 17 |
EBE Calls for Urgent Action |
| March 17 |
New Type of Botulinum Toxin Appears to Be Well Tolerated and May Help Reduce Forehead Wrinkles |
| March 18 |
Statement by Teva Pharmaceuticals on Eshoo-Barton Bill |
| March 18 |
Schering-Plough Europe Withdraws Its Marketing Authorisation Application For Cylatron (peginterferon alfa-2b) |
| March 18 |
Merck Statement on New Jersey Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Out-of-Pocket Vioxx Costs |
| March 18 |
PharmaLive.com Launches New Drugs Outlook Report |
| March 18 |
Reps. Eshoo, Inslee, and Barton Introduce Pathway for Biosimilars Act |
| March 18 |
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
| March 19 |
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction |
| March 19 |
Teva and Medicis Announce Settlement Agreement |
| March 19 |
FDA Advisory Committee Recommends Approval of Multaq (dronedarone) |
| March 19 |
Ex-Pfizer Manager Found Guilty of Obstruction |
| March 19 |
IMS Health Reports U.S. Prescription Sales Grew 1.3 Percent in 2008 to $291 Billion |
| March 20 |
Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization |
| March 20 |
Shire Files Lawsuit Against Mylan for Infringement of Fosrenol (Lanthanum Carbonate) Patent |
| March 20 |
Forest Laboratories, Inc. Announces FDA Approval of Lexapro for the Treatment of Major Depressive Disorder in Adolescents |
| March 20 |
Adventrx Announces Further Cost-Cutting Measures |
| March 23 |
Antimalaria Data on PolyMedix Antimicrobial Compounds Presented at Malaria Keystone Conference |
| March 24 |
Hospira Announces Plans to Optimize Operations, Increase Shareholder Value |
| March 24 |
Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to Vioxx |
| March 24 |
GSK Publishes 2008 Corporate Responsibility Report |
| March 24 |
Fablyn Approved in Europe for the Treatment of Osteoporosis |
| March 25 |
Sen. Grassley Calls on FDA Leader to Clarify Employees’ Right to Speak Up About Agency Matters |
| March 25 |
Pfizer Announces Completion of $13.5 Billion Debt Offering |
| March 25 |
The American Psychiatric Association Phases Out Industry-Supported Symposia |
| March 26 |
Roche Completes Tender Offer for Genentech |
| March 26 |
Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company |
| March 26 |
Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation |
| March 26 |
New Report Finds FDA is Overfunded, Overstaffed, and Costs Lives |
| March 26 |
CVS Caremark's Objectionable Drug Marketing Practices Raised at Massachusetts Joint Committee on Health Care Financing Hearing Today, According to CtW |
| March 27 |
Akela and Nventa Announce Merger |
| March 27 |
Evotec AG (DE) - Evotec Restructures and Implements "Evotec 2012 - Action Plan to Focus and Grow" |
| March 27 |
InSite Vision Announces Restructuring to Support 2009 Strategic Priorities |
| March 27 |
Osiris Discontinues Enrollment in Crohn's Study Due to Concerns with Trial Design |
| March 27 |
Senators Announce Bipartisan Proposal To Bring Generic Biologic Drugs To Market, Saving Billions In Medicare Costs |
| March 27 |
Takeda Establishes Presence in Canada |
| March 27 |
IMS, SDI Seek U.S. Supreme Court Review in Critical First Amendment Case |
| March 27 |
Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact |
| March 30 |
Adherex Reports 2008 Fiscal Results |
| March 30 |
Takeda Expands its Own Sales and Marketing Operations in Europe |
| March 30 |
EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts |
| March 31 |
Genzyme and Bayer HealthCare Enter New Strategic Agreement |
| March 31 |
Shire and GlaxoSmithKline Enter Agreement to Co-promote Vyvanse (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD |
| March 31 |
Dyax to Focus Resources on DX-88 Commercial Launch with Reduction in Force |
| March 31 |
Takeda to Create Global Centers of Excellence |
| March 31 |
Cardinal Health to Reduce Workforce to Respond to Economic Conditions |
| March 31 |
FDA Advisory Committee Unanimously Recommends Accelerated Approval of Avastin for Previously Treated Brain Cancer (Glioblastoma) |
| March 31 |
Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta and Declares Patent Invalid |
| March 31 |
Cialis, Cymbalta Lead 2008’s Most Recalled Drug Ads |
